Parents Say Cancer Prevention Best Reason for HPV Vaccination

Share this content:
Parents Say Cancer Prevention Best Reason for HPV Vaccination
Parents Say Cancer Prevention Best Reason for HPV Vaccination

THURSDAY, June 21, 2018 (HealthDay News) -- Parents view cancer prevention as the best reason for guideline-consistent human papillomavirus (HPV) vaccination, according to a study published online June 14 in Cancer Epidemiology, Biomarkers & Prevention.

Melissa B. Gilkey, Ph.D., from the University of North Carolina at Chapel Hill, and colleagues conducted an online survey of 1,177 parents of adolescents to quantify parent views on the best and worst reasons health care providers commonly give for guideline-consistent HPV vaccination.

The researchers found that parents viewed cancer prevention as the best reason for HPV vaccination (P < 0.001). Preventing a common infection, having lasting benefits, or being a safe vaccine were also endorsed (all P < 0.001). The worst reasons given by health care providers included: it is a scientific breakthrough; I got it for my own child; and your child is due (all P < 0.001).

"Our prior research indicates that providers give many different reasons for HPV vaccination, and the findings of this study suggest that they may do better to streamline their communication," Gilkey said in a statement. "Cancer prevention was clearly the most convincing reason for HPV vaccination. Reasons that have to do with sexual activity, scientific novelty, or providers' decisions for their own children may ultimately be distractions that are best avoided."

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Cap'n Crunch Cereal Recalled Due to Salmonella Scare

Cap'n Crunch Cereal Recalled Due to <i>Salmonella</i> Scare

No illnesses related to the products have been reported to date

FDA Approves First-Line Tx for Peripheral T-Cell Lymphoma

FDA Approves First-Line Tx for Peripheral T-Cell Lymphoma

Adcetris approved in combination with chemo to treat systemic anaplastic large cell lymphoma

FDA Warns Against Giving Honey-Filled Pacifiers to Infants

FDA Warns Against Giving Honey-Filled Pacifiers to Infants

Four infants in Texas hospitalized with botulism after using pacifiers containing honey

is free, fast, and customized just for you!




Already a member?

Sign In Now »